As of May 2024 IQVIA has a market cap of $42.12 Billion. This makes IQVIA the world's 470th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $42.12 B | -0.25% |
2023 | $42.22 B | 10.96% |
2022 | $38.05 B | -29.39% |
2021 | $53.89 B | 56.91% |
2020 | $34.35 B | 15.61% |
2019 | $29.71 B | 29.5% |
2018 | $22.94 B | 12.68% |
2017 | $20.36 B | 8.76% |
2016 | $18.72 B | 128.42% |
2015 | $8.19 B | 12.17% |
2014 | $7.30 B | 21.63% |
2013 | $6.00 B |
On May 18th, 2024 the market cap of IQVIA was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | -99.96% | Bahamas |
NRC Health
NRC | $0.74 B | -98.24% | ๐บ๐ธ USA |